LivaNova Reports Fourth-Quarter and Full-Year 2023 Results

LivaNova PLC , a market-leading medical technology company, today reported results for the quarter and full year ended December 31, 2023 and issued guidance for 2024.


Financial Summary and...

Related Keywords

London ,City Of ,United Kingdom ,Ukraine ,United States ,Vladimira Makatsaria ,Johnson Medtech ,Exchange Commission ,Company Group ,Vladimira Makatsaria The Company ,Alung Technologies Inc ,Nasdaq ,Livanova United States Inc ,Advanced Circulatory Support ,Chief Executive Officer ,Bill Kozy ,Interim Chief Executive Officer ,Board Chair ,Vlad Makatsaria ,Circulatory Support ,Company Group Chairman ,Livanova Board ,Conference Call ,Private Securities Litigation Reform Act ,Securities Act ,Middle East ,Annual Reports ,Quarterly Reports ,Current Reports ,United States Securities ,Livanova United States ,Months Ended December ,Ended December ,Financial Measures ,Three Months Ended ,Three Months Ended December ,Year Ended ,Year Ended December ,Medical Device Regulation ,Cash Exchangeable Senior Notes ,Term Facilities ,Stockholder Equity ,Heart Valves ,Markets ,